Unknown

Dataset Information

0

Effect of Different Phospholipids on ?-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer's Disease.


ABSTRACT: Alzheimer's disease (AD) is characterized by extracellular accumulation of amyloid-? peptide (A?), generated by proteolytic processing of the amyloid precursor protein (APP) by ?- and ?-secretase. A? generation is inhibited when the initial ectodomain shedding is caused by ?-secretase, cleaving APP within the A? domain. Therefore, an increase in ?-secretase activity is an attractive therapeutic target for AD treatment. APP and the APP-cleaving secretases are all transmembrane proteins, thus local membrane lipid composition is proposed to influence APP processing. Although several studies have focused on ?-secretase, the effect of the membrane lipid microenvironment on ?-secretase is poorly understood. In the present study, we systematically investigated the effect of fatty acid (FA) acyl chain length (10:0, 12:0, 14:0, 16:0, 18:0, 20:0, 22:0, 24:0), membrane polar lipid headgroup (phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine), saturation grade and the FA double-bond position on ?-secretase activity. We found that ?-secretase activity is significantly elevated in the presence of FAs with short chain length and in the presence of polyunsaturated FAs, whereas variations in the phospholipid headgroups, as well as the double-bond position, have little or no effect on ?-secretase activity. Overall, our study shows that local lipid membrane composition can influence ?-secretase activity and might have beneficial effects for AD.

SUBMITTER: Grimm MO 

PROVIDER: S-EPMC3634454 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer's Disease.

Grimm Marcus O W MO   Haupenthal Viola J VJ   Rothhaar Tatjana L TL   Zimmer Valerie C VC   Grösgen Sven S   Hundsdörfer Benjamin B   Lehmann Johannes J   Grimm Heike S HS   Hartmann Tobias T  

International journal of molecular sciences 20130313 3


Alzheimer's disease (AD) is characterized by extracellular accumulation of amyloid-β peptide (Aβ), generated by proteolytic processing of the amyloid precursor protein (APP) by β- and γ-secretase. Aβ generation is inhibited when the initial ectodomain shedding is caused by α-secretase, cleaving APP within the Aβ domain. Therefore, an increase in α-secretase activity is an attractive therapeutic target for AD treatment. APP and the APP-cleaving secretases are all transmembrane proteins, thus loca  ...[more]

Similar Datasets

| S-EPMC4217088 | biostudies-literature
| S-EPMC3376855 | biostudies-literature
| S-EPMC7026402 | biostudies-literature
| S-EPMC8627568 | biostudies-literature
| S-EPMC7443049 | biostudies-literature
| S-EPMC9076685 | biostudies-literature
| S-EPMC3322458 | biostudies-literature
| S-EPMC8543249 | biostudies-literature
| S-EPMC9198762 | biostudies-literature
| S-EPMC7533042 | biostudies-literature